§2764. Coverage for medically necessary infant formula
(REALLOCATED FROM TITLE 24-A, SECTION 2763)
              All individual health insurance policies, contracts and certificates must provide coverage for amino acid-based elemental infant formula for children 2 years of age and under in accordance with this section.
                                     
                                [RR 2007, c. 2, §11 (RAL).]
              
                  1. 
                                Determination of medical necessity. 
                                Coverage for amino acid-based elemental infant formula must be provided when a licensed physician has submitted documentation that the amino acid-based elemental infant formula is medically necessary health care as defined in section 4301‑A, subsection 10‑A, that the amino acid-based elemental infant formula is the predominant source of nutritional intake at a rate of 50% or greater and that other commercial infant formulas, including cow milk-based and soy milk-based formulas have been tried and have failed or are contraindicated. A licensed physician may be required to confirm and document ongoing medical necessity at least annually.
                                     
                                
                [RR 2007, c. 2, §11 (RAL).]
              
                  2. 
                                Method of delivery. 
                                Coverage for amino acid-based elemental infant formula must be provided without regard to the method of delivery of the formula.
                                     
                                
                [RR 2007, c. 2, §11 (RAL).]
              
                  3. 
                                Required diagnosis. 
                                Coverage for amino acid-based elemental infant formula must be provided when a licensed physician has diagnosed and through medical evaluation has documented one of the following conditions:
                                     
                                
                
                  A.
                                        Symptomatic allergic colitis or proctitis;
                                     
                                [RR 2007, c. 2, §11 (RAL).]
                
                  B.
                                        Laboratory- or biopsy-proven allergic or eosinophilic gastroenteritis;
                                     
                                [RR 2007, c. 2, §11 (RAL).]
                
                  C.
                                        A history of anaphylaxis;
                                     
                                [RR 2007, c. 2, §11 (RAL).]
                
                  D.
                                        Gastroesophageal reflux disease that is nonresponsive to standard medical therapies;
                                     
                                [RR 2007, c. 2, §11 (RAL).]
                
                  E.
                                        Severe vomiting or diarrhea resulting in clinically significant dehydration requiring treatment by a medical provider;
                                     
                                [RR 2007, c. 2, §11 (RAL).]
                
                  F.
                                        Cystic fibrosis; or
                                     
                                [RR 2007, c. 2, §11 (RAL).]
                
                  G.
                                        Malabsorption of cow milk-based or soy milk-based infant formula.
                                     
                                [RR 2007, c. 2, §11 (RAL).]
                [RR 2007, c. 2, §11 (RAL).]
              
                  4. 
                                Health savings accounts. 
                                Coverage for amino acid-based elemental infant formula under a health insurance policy, contract or certificate issued in connection with a health savings account as authorized under Title XII of the federal Medicare Prescription Drug, Improvement, and Modernization Act of 2003 may be subject to the same deductible and out-of-pocket limits that apply to overall benefits under the policy, contract or certificate.
                                     
                                
                [RR 2007, c. 2, §11 (RAL).]
              
                        SECTION HISTORY
                        
            RR 2007, c. 2, §11 (RAL).